G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 97 filers reported holding G1 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $133,357 | -39.7% | 17,547 | -19.1% | 0.00% | – |
| Q4 2021 | $221,000 | -22.5% | 21,690 | +2.1% | 0.00% | – |
| Q3 2021 | $285,000 | -42.3% | 21,246 | -5.6% | 0.00% | – |
| Q2 2021 | $494,000 | +3.1% | 22,508 | +13.0% | 0.00% | – |
| Q1 2021 | $479,000 | +28.1% | 19,915 | -4.1% | 0.00% | – |
| Q4 2020 | $374,000 | +57.8% | 20,767 | +1.0% | 0.00% | – |
| Q3 2020 | $237,000 | -52.3% | 20,554 | 0.0% | 0.00% | – |
| Q2 2020 | $497,000 | +106.2% | 20,554 | -6.2% | 0.00% | – |
| Q1 2020 | $241,000 | -55.5% | 21,909 | +6.8% | 0.00% | -100.0% |
| Q4 2019 | $542,000 | -24.4% | 20,516 | -2.8% | 0.00% | 0.0% |
| Q3 2019 | $717,000 | +10.1% | 21,116 | -0.5% | 0.00% | 0.0% |
| Q2 2019 | $651,000 | -10.3% | 21,219 | +52.7% | 0.00% | 0.0% |
| Q3 2018 | $726,000 | +7.7% | 13,892 | -10.4% | 0.00% | 0.0% |
| Q2 2018 | $674,000 | +68.1% | 15,507 | +43.6% | 0.00% | – |
| Q1 2018 | $401,000 | +190.6% | 10,800 | +54.9% | 0.00% | – |
| Q4 2017 | $138,000 | -19.3% | 6,974 | +1.2% | 0.00% | – |
| Q3 2017 | $171,000 | – | 6,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |